Evolus (EOLS) Shares Outstanding (2017 - 2026)
Evolus (EOLS) Shares Outstanding (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | 8.98 Bn |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 1.16 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 422.10 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 43.50 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | 31.59 Bn |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 100.50 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 497.70 Mn |
| 10 | Evolus | 393.73 Mn | 343.94 Mn | 48.90 Mn | 65.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.19 Mn |
| Dec 31, 2025 | 64.47 Mn |
| Sep 30, 2025 | 64.73 Mn |
| Jun 30, 2025 | 64.54 Mn |
| Mar 31, 2025 | 63.70 Mn |
| Dec 31, 2024 | 62.02 Mn |
| Sep 30, 2024 | 63.15 Mn |
| Jun 30, 2024 | 62.72 Mn |
| Mar 31, 2024 | 58.80 Mn |
| Dec 31, 2023 | 56.92 Mn |
| Sep 30, 2023 | 57.02 Mn |
| Jun 30, 2023 | 56.92 Mn |
| Mar 31, 2023 | 56.48 Mn |
| Dec 31, 2022 | 56.07 Mn |
| Sep 30, 2022 | 56.18 Mn |
| Jun 30, 2022 | 56.08 Mn |
| Mar 31, 2022 | 55.73 Mn |
| Dec 31, 2021 | 49.77 Mn |
| Sep 30, 2021 | 55.01 Mn |
| Jun 30, 2021 | 51.15 Mn |